CorMedix, Inc.
(NYSE Amex Equities : CRMD)

( )
CRMD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.66%441.551.0%$619.41m
ABTAbbott Laboratories 3.51%108.880.8%$575.34m
ISRGIntuitive Surgical, Inc. 2.40%709.542.4%$509.02m
DHRDanaher Corp. 2.09%215.410.7%$483.52m
MDTMedtronic Plc 1.05%103.770.6%$466.29m
BDXBecton, Dickinson & Co. 3.30%232.861.0%$394.78m
DXCMDexCom, Inc. 2.50%412.237.9%$336.01m
INOInovio Pharmaceuticals, Inc. 2.56%11.605.9%$326.63m
BSXBoston Scientific Corp. 1.17%38.201.0%$284.97m
SYKStryker Corp. 1.85%208.531.3%$282.98m
QDELQuidel Corp. 2.04%219.387.7%$281.50m
BAXBaxter International, Inc. 1.67%80.411.8%$248.30m
VARVarian Medical Systems, Inc. -0.03%171.959.1%$245.45m
ALGNAlign Technology, Inc. 2.25%327.366.4%$233.01m
EWEdwards Lifesciences Corp. 1.85%79.760.4%$225.71m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.